Steroid hormone receptor expression in nasopharyngeal angiofibromas: Consistent expression of estrogen receptor β

American Journal of Clinical Pathology

Volumn 125, Issue 6, 2006, Pages 832-837

  Montag, Anthony G ^a   Tretiakova, Maria ^a   Richardson, Mary ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Androgen receptor; Angiofibroma; Estrogen receptor ; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; STEROID RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HEMANGIOFIBROMA; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NASOPHARYNX ANGIOFIBROMA; NASOPHARYNX TUMOR; PERICYTE; PRIORITY JOURNAL; STROMA CELL;

ANGIOFIBROMA; ESTROGEN RECEPTOR BETA; HUMANS; IMMUNOENZYME TECHNIQUES; NASOPHARYNGEAL NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 33744463385     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/W5CM3A3NH7P4F5P2     Document Type: Article

References (46)

1. Mair EA, Battiata A, Casler JD. Endoscopic laser-assisted excision of juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg. 2003;129:454-459.
2. Brentani MM, Butugan O, Oshima CT, et al. Multiple steroid receptors in nasopharyngeal angiofibromas. Laryngoscope. 1989;99:398-401.
3. Hwang HC, Mills SE, Patterson K, et al. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11:1122-1126.
4. Robinson-Rechavi M, Escriva HG, Laudet V. The nuclear receptor superfamily. J Cell Sci. 2003;116:585-586.
5. Osborne CK, Schiff R, Fuqua SAW, et al. Estrogen receptor: current understanding of its activation and modulation. Clin Cancer Res. 2001;7:4338-4342.
6. Greene GL, Gilna P, Waterfield M, et al. Sequence and expression of human estrogen receptor complementary DNA. Science. 1986;231:1150-1154.
7. Kuiper GG, Enmark E, Pelto-Huiko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93:5925-5930.
8. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel estrogen receptor. FEBS Lett. 1996;392:49-53.
9. Hart LL, Davie JR. The estrogen receptor: more than the average transcription factor. Biochem Cell Biol. 2002;80:335-341.
10. Kelley ST, Thackray VG. Phylogenetic analyses reveal ancient duplication of estrogen receptor isoforms. J Mol Evol. 1999;49:609-614.
11. Lewandowski S, Kalita K, Kaczmarek L. Estrogen receptor beta: potential functional significance of a variety of mRNA isoforms. FEBS Lett. 2002;524:1-5.
12. Pettersson K, Gustafsson JA. Role of estrogen receptor beta in estrogen action. Ann Rev Physiol. 2001;63:165-192.
13. Taylor AH, Al-Azzawi F. Immunolocalization of oestrogen receptor beta in human tissues. J Mol Endocrinol. 2000;24:145-155.
14. Chu S, Mamers P, Burger HG, et al. Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors. J Clin Endocrinol Metab. 2000;85:1200-1205.
15. Shaaban AM, Jarvis C, Moore F, et al. Prognostic significance of estrogen receptor beta in epithelial hyperplasia of usual type with known outcome. Am J Surg Pathol. 2005;29:1593-1599.
16. Leav I, Lau KM, Adams JY, et al. Comparative studies of estrogen receptors beta and alpha and androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol. 2001;159:79-92.
17. Bukovsky A, Caudle MR, Cekanova M, et al. Placental expression of estrogen receptor beta and its hormone binding variant: comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells. Reprod Biol Endocrinol. 2003;1:36.
18. Schiff M. Juvenile nasopharyngeal angiofibroma: a theory of pathogenesis. Laryngoscope. 1959;84:2181-2194.
19. Johns ME, MacLeod RM, Cantrell RW. Estrogen receptors in nasopharyngeal angiofibromas. Laryngoscope. 1980;90:628-634.
20. Vonderhaar V, Mueller GC. Binding of estrogen receptor to estradiol immobilized on insoluble resins. Biochim Biophys Acta. 1969;176:626-631.
21. McCarty KSJ, McCarty KSS. Histochemical approaches to steroid receptor analyses. Semin Diagn Pathol. 1984;1:297-308.
22. King WJ, DeSombre ER, Jensen EV, et al. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res. 1985;45:293-304.
23. Lee DW, Ramanath R, Meyer JS, et al. Hormonal receptor determination in juvenile nasopharyngeal angiofibromas. Cancer Res. 1980;46:547-551.
24. Molteni A, Warpeha RL, Brizio-Molteni L, et al. Estradiol receptor-binding protein in head and neck neoplastic and normal tissue. Arch Surg. 1981;116:207-210.
25. Antonelli AR, Capperllo J, Di Lorenzo D, et al. Diagnosis, staging, and treatment of juvenile nasopharyngeal angiofibroma (JNA). Laryngoscope. 1987;97:1319-1325.
26. Farag MM, Ghanimah SE, Ragaie A, et al. Hormonal receptors in juvenile nasopharyngeal angiofibroma. Laryngoscope. 1987;97:208-211.
27. Amedee R, Klaeyle D, Mann W, et al. Juvenile angiofibromas: a 40 year surgical experience. ORL J Otorhinolaryngol Relat Spec. 1989;51:56-61.
28. Gatalica Z. Immunohistochemical analysis of steroid hormone receptors in nasopharyngeal angiofibromas. Cancer Lett. 1998;127:89-93.
29. Liang J, Yi Z, Lianq P. The nature of juvenile nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg. 2000;123:475-481.
30. Kumagami H. Sex hormones in juvenile nasopharyngeal angiofibroma tissue. Auris Nasus Larynx. 1993;20:131-135.
31. Rubanyi GM, Kauser K, Johns A. Role of estrogen receptors in the vascular system. Vascul Pharmacol. 2002;38:81-88.
32. Critchely HO, Brenner RM, Henderson TA, et al. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab. 2001;86:1370-1378.
33. Chaudhuri PK, Walker MJ, Beattie CW, et al. Distribution of steroid hormone receptors in human soft tissue sarcomas. Surgery 1981;90:149-153.
34. Weiss SW, Langloss JM, Schmookler BM, et al. Estrogen receptor protein in bone and soft tissue tumors. Lab Invest. 1986;54:689-694.
35. Suda A, Sato T, Watanabe Y, et al. Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors. Nippon Seikeigeka Gakkai Zasshi. 1990;64:814-823.
36. Hayry P, Reitamo JJ, Vihko R, et al. The desmoid tumor, III: a biochemical and genetic analysis. Am J Clin Pathol. 1982;77:681-685.
37. Lim CL, Walker MJ, Mehta RR, et al. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol. 1986;22:583-587.
38. Maddalozzo J, Tenta LT, Hutchinson LR, et al. Juvenile fibromatosis: hormonal receptors. Int J Pediatr Otorhinolaryngol. 1993;25:191-199.
39. Rasbridge SA, Gillett CE, Millis RR. Oestrogen and progesterone receptor expression in mammary fibromatosis. J Clin Pathol. 1993;46:349-351.
40. Devouassoux-Shisheboran M, Schammel MD, Man YG, et al. Fibromatosis of the breast: age correlated morphofunctional features of 33 cases. Arch Pathol Lab Med. 2000;124:276-280.
41. Sorenson A, Keller J, Nielsen OS, et al. Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1-27 years. Acta Orthop Scand. 2002;73:213-219.
42. Deyrup AT, Tretiakova M, Montag AG. Estrogen receptor-beta expression in extra-abdominal fibromatoses: an analysis of 40 cases. Cancer. 2006;106:208-213.
43. Pruthi S, Reynolds C, Johnson RE, et al. Tamoxifen in the management of pseudoangiomatous stromal hyperplasia. Breast J. 2001;7:434-439.
44. Picariello L, Tonelli F, Brandi ML. Selective oestrogen receptor modulators in desmoid tumours. Expert Opin Investig Drugs. 2004;13:1457-1468.
45. Tonelli F, Ficari F, Valanzano R, et al. Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene. Tumori. 2003;89:391-396.
46. Jordan VC. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines, 1: receptor interactions. J Med Chem. 2003;46:883-908.